companydata.dkcompanydata.dk

Ascendis Pharma Oncology Division A/S: Financial statements 2023

CVR: 41034076

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Ascendis Pharma Oncology Division A/S (CVR 41034076) has filed annual accounts for 2023. In 2023, the company reported a gross profit of EUR -140,146,399 and a net result of EUR -144,110,203 compared with EUR -64,912,248 the year before. Equity in the 2023 report amounted to EUR -285,131,102.

Gross Profit
EUR -140,146,399
Profit/Loss
EUR -144,110,203
Equity
EUR -285,131,102
Total Assets
EUR 456,642
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--140.1M EUR-144.1M EUR-285.1M EUR0
2022--62.4M EUR-64.9M EUR-141M EUR0
2021--46.7M EUR-48M EUR-76.1M EUR0
2020--35.7M EUR-36.1M EUR-28.1M EUR0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Ascendis Pharma Oncology Division A/S: The 2022 annual report is outMar 24, 2023

Ascendis Pharma Oncology Division A/S has published its annual report for 2022. Gross profit came to DKK -62,367,388, and the net result was DKK -64,912,248.

About Ascendis Pharma Oncology Division A/S

Ascendis Pharma Oncology Division A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jan Møller Mikkelsen. The board consists of Michael Wolff Jensen (chair), Anni Lotte Kirstine Pedersen and Jan Møller Mikkelsen. The company is owned by ASCENDIS PHARMA A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of EUR -85,226,000 and a net result of EUR -110,131,000 compared with EUR -106,375,000 the year before. Equity in the 2025 report amounted to EUR -501,637,000.

Source: annual report 2025, Danish Business Authority

Other financial years